Commitments and Contingencies

12 Months Ended

Dec. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

14. Commitments and Contingencies

Leases

The Company leases an office space in Houston, Texas under an operating lease that expires in September 2022. The Company also sub-leases from ElevateBio a portion of its office space in Cambridge, Massachusetts on a month-to-month basis, which was terminated effective January 31, 2022. The Company entered into a new lease agreement and a sublease agreement in 2021 for the lease of property in Waltham, Massachusetts. See Note 5 for additional information.

Purchase Obligation

The Company entered into a DMS Agreement (see Note 5) whereby the Company is required to purchase at least one batch of product per month for both dedicated manufacturing suites, totaling $0.3 million per month, regardless of the Company’s demand. The monthly batch product purchases related to the DMS Agreement will cease in July 2023.

Legal Proceedings

From time to time, in the ordinary course of business, the Company is subject to litigation and regulatory examinations as well as information gathering requests, inquiries and investigations. At December 31, 2021, there were no matters which would have a material impact on the Company’s financial results.